Mehai Technology IPO vs Trident Texofab IPO

Comparison between Mehai Technology IPO and Trident Texofab IPO.

IPO Details

Mehai Technology IPO is a SME Fixed Price IPO proposed to list at BSE SME while Trident Texofab IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Mehai Technology IPO is up to ₹5.69 Cr whereas the issue size of the Trident Texofab IPO is up to ₹3.34 Cr. The final issue price of Mehai Technology IPO is ₹40.00 per share and of Trident Texofab IPO is ₹30.00 per share.

 Mehai Technology IPOTrident Texofab IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹40.00 per share₹30.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size3000 shares4000 shares
Fresh Issue Size14,22,000 shares11,12,000 shares
Fresh Issue Size (Amount)up to ₹5.69 Crup to ₹3.34 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total14,22,000 shares11,12,000 shares
Issue Size Total (Amount)up to ₹5.69 Crup to ₹3.34 Cr

IPO Timetable

Mehai Technology IPO opens on Sep 25, 2017, while Trident Texofab IPO opens on Sep 21, 2017. The closing date of Mehai Technology IPO and Trident Texofab IPO is Sep 28, 2017, and Sep 26, 2017, respectively.

 Mehai Technology IPOTrident Texofab IPO
Issue OpenSep 25, 2017Sep 21, 2017
Issue CloseSep 28, 2017Sep 26, 2017
Basis Of Allotment (Tentative)Oct 04, 2017Sep 29, 2017
Listing date (Tentative)Oct 09, 2017Oct 05, 2017

Financials & KPIs

Mehai Technology IPO P/E ratio is , as compared to Trident Texofab IPO P/E ratio of .

 Mehai Technology IPOTrident Texofab IPO
Financials

Company Financials (Restated)

Period Ended30 Apr 201731 Mar 201731 Mar 201631 Mar 2015
Assets10.328.510.960.55
Total Income0.295.221.240.62
Profit After Tax0.040.310.010.01
NET Worth6.400.420.110.09
Reserves and Surplus5.170.330.030.01
Total Borrowing0.253.25
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets24.5037.9928.42
Total Income76.1966.0362.65
Profit After Tax0.340.060.18
NET Worth3.803.463.43
Reserves and Surplus3.473.133.10
Total Borrowing5.182.983.56
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.95%100.00%
Promoter Shareholding (Post-Issue)71.95%70.57%
Market Cap₹21.42 Cr.₹11.99 Cr.

Shares Offered

In the Mehai Technology IPO Retail Individual Investors (RII) are offered 7,11,000 shares while in Trident Texofab IPO retail investors are offered 7,11,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Mehai Technology IPO and 0 shares in Trident Texofab IPO.

 Mehai Technology IPOTrident Texofab IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation78,000 shares64,000 shares
QIB0 shares0 shares
NII7,11,000 shares5,56,000 shares
RII7,11,000 shares5,56,000 shares
Employee0 shares0 shares
Total14,22,000 shares11,12,000 shares

Bids Received (Subscription)

Mehai Technology IPO subscribed 1.73x in total, whereas Trident Texofab IPO subscribed 8.09x.

 Mehai Technology IPOTrident Texofab IPO
NII (times)0.86x3.45x
RII (times)2.60x12.73x
Total (times)1.73x8.09x

Compare with others

Compare: